Survival After Blood Transfusion in the French Administrative Regions of Burgundy and Franche-Comté

Red blood cell transfusion (RBC) is the main symptomatic treatment for severe anemia. RBC transfusion has proven its efficacy regarding mortality and morbidity, but it is not without side effects. The infectious side effects of transfusion are largely considered under control, non-infectious side effects are taking center stage. Seeking explanations for the beneficial and deleterious effects of RBC transfusions is necessary to ensure the safe and optimal use of this precious resource.

The investigators aim to study the impact of donor and RBC characteristics on patient survival.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Erythrocyte Transfusion for All Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Centre d'Investigation Clinique, CHU de Besançon, Besançon, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aged 18 and over
Erythrocyte Transfusion between 2007 and 2011
Performed at the University Hospital of Besançon or Dijon

Exclusion criteria

Transfusion of any blood product prior to January 1st, 2007

Treatment and study plan

Primary outcomes

Survival

Time frame: 12 months

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Besancon

Other

Collaborators

Centre Hospitalier Universitaire Dijon
Etablissement Français du Sang

Registry information

Acronym: STeF-BFC

Important dates

Study start: 2013
Primary completion: 2015
Study completion: 2015
First posted: Aug 2, 2016
Registry last updated: Aug 2, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.